Vascular endothelial growth factor receptor 1 (Flt1) and apoptosis in the preeclamptic placenta and effects of in vivo anti-hypertensive exposure

Hypertens Pregnancy. 2008;27(4):361-73. doi: 10.1080/10641950802020552.

Abstract

Objective: To test the hypothesis that vascular endothelial growth factor receptor 1 (Flt1) is negatively correlated with apoptosis in preeclampsia placentae, and to examine the effects of antihypertensive medication on apoptosis.

Methods: Flt1 and TUNEL immunoreactivity were quantitatively compared in the stromal decidual cells, villous trophoblasts, and endothelial cells of placentae from uncomplicated pregnancies (NP, n = 34) to those in patients with preeclampsia (PE, n = 30), and those in patients with preeclampsia with superimposed intrauterine growth restriction (PE + IUGR, n = 7). Further analyses determined any correlations with the antepartum use of the antihypertensives clonidine and hydralazine.

Results: There was no difference in either Flt1 or TUNEL when comparing PE placentae (with or without IUGR) with NP. There were no correlations with the use of the antihypertensives.

Conclusion: Apoptotic levels do not correlate with Flt1 in preeclampsia placentae and are not regulated by in vivo exposure to the antihypertensives clonidine and hydralazine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antihypertensive Agents / pharmacology*
  • Apoptosis / drug effects*
  • Case-Control Studies
  • Clonidine / pharmacology
  • Female
  • Fetal Growth Retardation / metabolism
  • Humans
  • Hydralazine / pharmacology
  • Immunohistochemistry
  • Placenta / metabolism*
  • Pre-Eclampsia / metabolism*
  • Pregnancy
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism*

Substances

  • Antihypertensive Agents
  • Hydralazine
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1
  • Clonidine